Volta Labs, Watchmaker Genomics collaborate to launch Callisto Complete Kit for DNA EF Library Prep: Boston Wednesday, February 25, 2026, 18:00 Hrs [IST] At the Advances in Genome ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor ...

Intellectual property theft is still a fundamental part of what makes these kinds of models work.

Transmission-scale AI campus structured for phased grid delivery as ERCOT faces record large-load interconnection ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).

For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and long-term disability by enabling early detection of metabolic and endocrine ...

At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation ...

Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and early clinical response within seven days ...

After more than a century of monopoly control under Eskom, South Africa is shifting towards a competitive multi-market electricity system anchored by a wholesale market and supported by bilateral ...

An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up ...

Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, as well as the emerging role of immunotherapy, according to a new review ...